These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 19176795

  • 1. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.
    Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR, Nicocia G, Buemi M.
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):337-44. PubMed ID: 19176795
    [Abstract] [Full Text] [Related]

  • 2. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER, Lee D, Cai MM, Tomlinson LA, Ford ML, McMahon LP, Holt SG.
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [Abstract] [Full Text] [Related]

  • 3. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
    Rhee H, Shin N, Shin MJ, Yang BY, Kim IY, Song SH, Lee DW, Lee SB, Kwak IS, Seong EY.
    Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
    [Abstract] [Full Text] [Related]

  • 4. Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease.
    Liu KD, Yang W, Anderson AH, Feldman HI, Demirjian S, Hamano T, He J, Lash J, Lustigova E, Rosas SE, Simonson MS, Tao K, Hsu CY, Chronic Renal Insufficiency Cohort (CRIC) study investigators.
    Kidney Int; 2013 May; 83(5):909-14. PubMed ID: 23344473
    [Abstract] [Full Text] [Related]

  • 5. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
    Xiang D, Zhang H, Bai J, Ma J, Li M, Gao J, Wang C.
    Int J Clin Exp Pathol; 2014 May; 7(10):7172-81. PubMed ID: 25400814
    [Abstract] [Full Text] [Related]

  • 6. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients.
    Malyszko J, Malyszko JS, Bachorzewska-Gajewska H, Poniatowski B, Dobrzycki S, Mysliwiec M.
    Transplant Proc; 2009 May; 41(1):158-61. PubMed ID: 19249502
    [Abstract] [Full Text] [Related]

  • 7. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease.
    Shen SJ, Hu ZX, Li QH, Wang SM, Song CJ, Wu DD, He JL, Guan JC, Shan JP.
    Nephrology (Carlton); 2014 Mar; 19(3):129-35. PubMed ID: 24397346
    [Abstract] [Full Text] [Related]

  • 8. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.
    Bhavsar NA, Köttgen A, Coresh J, Astor BC.
    Am J Kidney Dis; 2012 Aug; 60(2):233-40. PubMed ID: 22542304
    [Abstract] [Full Text] [Related]

  • 9. Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease.
    Bolignano D, Lacquaniti A, Coppolino G, Campo S, Arena A, Buemi M.
    Kidney Blood Press Res; 2008 Aug; 31(4):255-8. PubMed ID: 18600028
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD.
    Alderson HV, Ritchie JP, Pagano S, Middleton RJ, Pruijm M, Vuilleumier N, Kalra PA.
    Clin J Am Soc Nephrol; 2016 Dec 07; 11(12):2141-2149. PubMed ID: 27852662
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Peralta CA, Katz R, Bonventre JV, Sabbisetti V, Siscovick D, Sarnak M, Shlipak MG.
    Am J Kidney Dis; 2012 Dec 07; 60(6):904-11. PubMed ID: 22749388
    [Abstract] [Full Text] [Related]

  • 14. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, van Goor H, Wetzels JF.
    Nephrol Dial Transplant; 2011 Nov 07; 26(11):3581-8. PubMed ID: 21467131
    [Abstract] [Full Text] [Related]

  • 15. Plasma neutrophil gelatinase-associated lipocalin in acute kidney injury superimposed on chronic kidney disease after cardiac surgery: a multicenter prospective study.
    Doi K, Urata M, Katagiri D, Inamori M, Murata S, Hisagi M, Ono M, Matsubara T, Ishii T, Yahagi N, Nangaku M, Noiri E.
    Crit Care; 2013 Nov 12; 17(6):R270. PubMed ID: 24215663
    [Abstract] [Full Text] [Related]

  • 16. Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes.
    Singer E, Elger A, Elitok S, Kettritz R, Nickolas TL, Barasch J, Luft FC, Schmidt-Ott KM.
    Kidney Int; 2011 Aug 12; 80(4):405-14. PubMed ID: 21412214
    [Abstract] [Full Text] [Related]

  • 17. Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study.
    Yang YH, He XJ, Chen SR, Wang L, Li EM, Xu LY.
    Endocrine; 2009 Aug 12; 36(1):45-51. PubMed ID: 19390997
    [Abstract] [Full Text] [Related]

  • 18. Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study.
    Hollmen ME, Kyllönen LE, Inkinen KA, Lalla ML, Merenmies J, Salmela KT.
    Crit Care; 2011 Aug 12; 15(3):R121. PubMed ID: 21545740
    [Abstract] [Full Text] [Related]

  • 19. Comparative assessment of neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C as early biomarkers for early detection of renal failure in patients with hypertension.
    Gharishvandi F, Kazerouni F, Ghanei E, Rahimipour A, Nasiri M.
    Iran Biomed J; 2015 Aug 12; 19(2):76-81. PubMed ID: 25864811
    [Abstract] [Full Text] [Related]

  • 20. Plasma neutrophil gelatinase-associated lipocalin and kidney function decline and kidney disease-related clinical events in older women.
    Lim WH, Lewis JR, Wong G, Teo R, Lim EM, Byrnes E, Prince RL.
    Am J Nephrol; 2015 Aug 12; 41(2):156-64. PubMed ID: 25824561
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.